[Featured Stock] Kumho HT Hits Upper Limit on News of Absorbing New Drug Development Company
[Asia Economy Reporter Ji Yeon-jin] Kumho HT's stock price surged to the upper limit on the 27th following the news that it will absorb and merge its new drug development affiliate, Dynona.
Hot Picks Today
![Airlines Set to Benefit in the Long Term Despite Fuel Cost Surge: "It's Actually Good" [Weekend Money]](https://cwcontent.asiae.co.kr/asiaresize/93/2025062508161320621_1750806973.jpg)
Airlines Set to Benefit in the Long Term Despite Fuel Cost Surge: "It's Actually Good" [Weekend Money]
- "Suspicious Timing?"...Trump Traded Stocks After Praising Wartime Capabilities
- "I Went to 10 Convenience Stores and Still Couldn't Buy It": The Bread Sensation That Sold 100 Million Units Already [The Way We Shop Now]
- There Is a Distinct Age When Physical Abilities Decline Rapidly... From What Age Do Strength and Endurance Drop?
- "Contact Me First If Houses Are Built": Wealthy Clients Eyeing... Will Ultra-High-End Residences Worth 20 Billion Won Be Developed? [Real Estate AtoZ]
As of 10 a.m. on the same day, Kumho HT was trading at 3,315 won, up 30% from the previous day. The company is a specialized manufacturer of automotive lighting, producing lighting for all parts of vehicles including front and rear lighting devices, instrument panels, and interior lights. On this day, it announced that it had decided to absorb and merge the new drug development company Dynona.
This content was produced with the assistance of AI translation services.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
